10/21/2024
6:31 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:00 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
4:10 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
6:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
3:05 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
4:00 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:28 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/15/2024
7:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
7:05 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form NT 10-Q | |
08/14/2024
8:46 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Ramdeen Timothy R. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
4:20 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
9:54 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:16 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/23/2024
3:05 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
7:00 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
1:33 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
1:34 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
7:03 AM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/20/2024
3:30 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:23 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form PRER14A | |
06/14/2024
4:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B3 | |
06/12/2024
5:23 PM | Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
11:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form EFFECT | |
06/05/2024
4:15 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2024
4:25 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/30/2024
4:18 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K/A | |
05/30/2024
4:32 PM | Entero Therapeutics, Inc. (Filer)
Entero Therapeutics, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024
6:16 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
4:26 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
4:26 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:59 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B5 | |
05/08/2024
4:16 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K/A | |
03/29/2024
3:16 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
4:00 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:40 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
3:31 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
03/15/2024
5:00 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
5:00 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
5:05 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
KHOSLA CHAITAN PHD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
5:05 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Syage Jack (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
5:10 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form DEFA14A | |
Rigged election? (Ad) Porter Stansberry’s viral Breaking Point 2024 broadcast has now been by tens of thousands of Americans who finally understand the grim reality of our next election.
With November 5 just around the corner, it’s imperative for your financial future that you read Porter’s message below now and then watch Breaking Point before it’s too late.  Watch this video, it is being taken down Monday night |
03/14/2024
5:09 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:29 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 424B5 | |
02/14/2024
1:45 PM | ARMISTICE CAPITAL, LLC (Filed by)
First Wave BioPharma, Inc. (Subject)
First Wave BioPharma, Inc. (Subject)
Entero Therapeutics (Subject)
| Form SC 13G/A | |
01/17/2024
11:15 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form EFFECT | |
01/08/2024
4:14 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/04/2024
4:12 PM | BORKOWSKI EDWARD (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:13 PM | Coelho Mary Theresa (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:13 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Riddell Alastair (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:14 PM | CASAMENTO CHARLES J (Reporting)
First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
7:22 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
6:54 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
Romano Sarah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
6:55 PM | First Wave BioPharma, Inc. (Issuer)
First Wave BioPharma, Inc. (Issuer)
Entero Therapeutics (Issuer)
SAPIRSTEIN JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
11:21 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form RW | |
12/27/2023
4:23 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
7:04 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-1/A | |
12/27/2023
5:15 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
6:00 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
8:48 PM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form S-1/A | |
12/14/2023
8:15 AM | First Wave BioPharma, Inc. (Filer)
First Wave BioPharma, Inc. (Filer)
Entero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
